Semaglutide Injection

Semaglutide Injection is a research-grade formulation containing a synthetic analog of human glucagon-like peptide-1 (GLP-1), designed for laboratory investigation of incretin hormone pathways and glucose homeostasis mechanisms. This peptide is classified as a GLP-1 receptor agonist and is utilized in preclinical research examining metabolic regulation, pancreatic beta-cell function, and incretin signaling cascades. Semaglutide is a modified GLP-1 analog engineered with structural modifications to enhance stability and extend half-life compared to native GLP-1, making it suitable for sustained experimental applications. This product is formulated as a research-grade injectable solution for controlled delivery in experimental models and is intended solely for scientific research purposes and is not for human or veterinary use.